Breaking News, Collaborations & Alliances

Strata Oncology Expands Clinical Collaboration with Pfizer

Pfizer to provide therapeutics approved in late-stage cancer indications for Strata PATH trial.

Author Image

By: Charlie Sternberg

Associate Editor

Strata Oncology, Inc. a next-generation precision oncology company enabling smarter and earlier cancer treatment, has expanded its clinical collaboration with Pfizer in the Strata Precision Indications for Approved Therapies (Strata PATH) trial.   Strata PATH is a prospective pan-tumor therapeutic trial designed to evaluate the efficacy and safety of multiple FDA-approved cancer therapies in new, biomarker-guided patient populations. Pfizer will provide Braftovi (encorafenib), Mektovi (binimet...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters